Evidence map›Paper›PMID 34141524›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2021

Hybrid Living Capsules Autonomously Produced by Engineered Bacteria.

Daniel P Birnbaum, Avinash Manjula-Basavanna, Anton Kan, Blaise L Tardy, Neel S Joshi

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Hybrid Living Capsules Autonomously Produced by Engineered Bacteria.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Daniel P BirnbaumJohn A. Paulson School of Engineering and Applied Sciences Harvard University Cambridge MA 02138 USA.ORCID 0000-0002-3576-4954
Avinash Manjula-BasavannaDepartment of Chemistry and Chemical Biology Northeastern University Boston MA 02115 USA.
Anton KanWyss Institute for Biologically Inspired Engineering Harvard University Boston MA 02115 USA.
Blaise L TardyDepartment of Bioproducts and Biosystems Aalto University Espoo FI-00076 Finland.
Neel S JoshiDepartment of Chemistry and Chemical Biology Northeastern University Boston MA 02115 USA.ORCID 0000-0001-8236-3566
Northeastern University · USAalto University · FIHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial cellulose (BC) has excellent material properties and can be produced sustainably through simple bacterial culture, but BC-producing bacteria lack the extensive genetic toolkits of model organisms such as

Indexed as

BioengineeringCapsulesCelluloseCoculture TechniquesCulture MediaEscherichia coliGluconacetobacterNanofibersCapsulesCelluloseCulture Mediabacterial cellulosebiomineralizationcurli nanofibersengineered living materialssynthetic biology

Identifiers

PMID34141524
PMCPMC8188213
OpenAlexW3157504789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.